My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 520

    1.

    Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.

    Zhang WY, Po AL, Dua HS, Azuara-Blanco A.

    Br J Ophthalmol. 2001 Aug;85(8):983-90.PMID: 11466259 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

    Li N, Chen XM, Zhou Y, Wei ML, Yao X.

    Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.PMID: 17073898 [PubMed - indexed for MEDLINE]Related articles

    3.

    Latanoprost : an update of its use in glaucoma and ocular hypertension.

    Perry CM, McGavin JK, Culy CR, Ibbotson T.

    Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

    4.

    A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

    Watson P, Stjernschantz J.

    Ophthalmology. 1996 Jan;103(1):126-37.PMID: 8628543 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.

    Camras CB.

    Ophthalmology. 1996 Jan;103(1):138-47.PMID: 8628544 [PubMed - indexed for MEDLINE]Related articles

    6.

    A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.

    Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.

    Ophthalmology. 1999 Mar;106(3):550-5.PMID: 10080213 [PubMed - indexed for MEDLINE]Related articles

    7.

    Latanoprost: experience of 2-year treatment in Scandinavia.

    Alm A, Widengård I.

    Acta Ophthalmol Scand. 2000 Feb;78(1):71-6.PMID: 10726794 [PubMed - indexed for MEDLINE]Related articles

    8.

    Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

    Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

    Am J Ophthalmol. 2001 Oct;132(4):472-84.PMID: 11589866 [PubMed - indexed for MEDLINE]Related articles

    9.

    A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.

    Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group.

    Br J Ophthalmol. 2004 Feb;88(2):199-203.PMID: 14736774 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

    Easthope SE, Perry CM.

    Drugs Aging. 2002;19(3):231-48. Review.PMID: 12027782 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

    Alm A, Stjernschantz J.

    Ophthalmology. 1995 Dec;102(12):1743-52.PMID: 9098273 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

    Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups.

    Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.PMID: 14982045 [PubMed - indexed for MEDLINE]Related articles

    13.

    A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

    Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.

    Emmerich KH.

    Graefes Arch Clin Exp Ophthalmol. 2000 Jan;238(1):19-23.PMID: 10664047 [PubMed - indexed for MEDLINE]Related articles

    15.

    Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

    Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

    Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

    16.

    24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.

    García Sanchez J.

    Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204.PMID: 11071026 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of latanoprost compared with timolol in African-American, Asian, Caucasian, and Mexican open-angle glaucoma or ocular hypertensive patients.

    Hedman K, Larsson LI.

    Surv Ophthalmol. 2002 Aug;47 Suppl 1:S77-89.PMID: 12204703 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.

    Mishima HK, Masuda K, Kitazawa Y, Azuma I, Araie M.

    Arch Ophthalmol. 1996 Aug;114(8):929-32.PMID: 8694726 [PubMed - indexed for MEDLINE]Related articles

    20.

    A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

    DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

    Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity